Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 8 February 2002:
Vol. 295. no. 5557, pp. 1002 - 1005
DOI: 10.1126/science.1068443
Prev | Table of Contents | Next

Viewpoint

Artificial Blood

Jerry E. Squires

Blood substitutes are under development for transfusion in place of donor blood during emergencies and lengthy surgeries. The first generation of blood substitutes is currently in clinical trials.

American Red Cross Biomedical Services, Arlington, VA 22307, USA. E-mail: squiresj{at}usa.redcross.org

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Regional myocardial perfusion under exchange transfusion with liposomal hemoglobin: in vivo and in vitro studies using rat hearts.
T. Matsumoto, T. Asano, K. Mano, H. Tachibana, M. Todoh, M. Tanaka, and F. Kajiya (2005)
Am J Physiol Heart Circ Physiol 288, H1909-H1914
   Abstract »    Full Text »    PDF »
Neutral and Anionic Liposome-Encapsulated Hemoglobin: Effect of Postinserted Poly(ethylene glycol)-distearoylphosphatidylethanolamine on Distribution and Circulation Kinetics.
V. D. Awasthi, D. Garcia, R. Klipper, B. A. Goins, and W. T. Phillips (2004)
J. Pharmacol. Exp. Ther. 309, 241-248
   Abstract »    Full Text »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)